http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#head http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#assertion http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#assertion http://bio2rdf.org/drugbank:DB00541 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB00705 http://bio2rdf.org/drugbank:DB00705 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB00705 http://bio2rdf.org/drugbank_resource:DB00541_DB00705 http://purl.org/dc/terms/identifier drugbank_resource:DB00541_DB00705 http://bio2rdf.org/drugbank_resource:DB00541_DB00705 http://purl.org/dc/terms/title DDI between Vincristine and Delavirdine - Delavirdine, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Delavirdine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00541_DB00705 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00541_DB00705 http://www.w3.org/2000/01/rdf-schema#label DDI between Vincristine and Delavirdine - Delavirdine, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Delavirdine is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB00705] http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#signature.MCwCFEhdrR46Ftz- http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#signature.MCwCFEhdrR46Ftz- http://purl.org/nanopub/x/hasSignature MCwCFEhdrR46Ftz+R3T6tAf3GQ4h85OsAhQWTjndEQ9Khmo+74HTo7yxLoOepg== http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#signature.MCwCFEhdrR46Ftz- http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://purl.org/dc/terms/created 2018-03-30T11:12:55.154+02:00 http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4#signature.MCwCFEhdrR46Ftz- http://bio2rdf.org/drugbank_resource:DB00541_DB00705_nanopub.RA-8nPD8tv9rwnlLS9R7NOcR8w2Vu21S0kdWB2fAwuRM4 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234